06 June 2025 Canada Border Services Agency updates customs notice for surtax remission
On 20 May 2025, the Canada Border Services Agency (CBSA) released a revised version of Customs Notice 25-19, United States Surtax Remission Order (2025) (Customs Notice). This notice, which was originally published on 17 April 2025, contains new information about the application of the United States Surtax Remission Order (2025) (Remission Order).1 The Remission Order provides a six-month relief period for surtaxes on certain goods imported from the United States (US), including goods used to support public health, health care, public safety and national security objectives, as well as goods imported for use in Canadian manufacturing, processing, and food and beverage packaging. The Customs Notice contains guidance on the eligibility of goods for remission under the Remission Order. The information does not have the force of law and reflects the CBSA's interpretation of the relevant provisions of the Remission Order. As the updated Customs Notice contains information that is not found in the Remission Order, importers should seek advice regarding the application of the Remission Order. This Tax Alert provides a brief summary of the relief provisions contained in the Remission Order and highlights the new guidance in the revised Customs Notice. The Remission Order was issued on 16 April 2025 under section 115 of the Customs Tariff, S.C. 1997, c. 36. It provides a temporary six-month relief period for surtaxes paid or payable under the United States Surtax Order (2025-1), the United States Surtax Order (Steel and Aluminum 2025) or the United States Surtax Order (Motor Vehicles 2025) (collectively, the Surtax) in respect of eligible goods. For eligible goods, certain conditions must be met for an importer to obtain relief under the Remission Order. These include:
Under section 1 of the Remission Order, remission is available for goods imported by or on behalf of certain prescribed organizations or authorities. For example, these entities include government/clinical health research organizations, organizations that produce/store medical countermeasures, the office of a public health official, law enforcement agencies, the Canadian Forces and the Department of National Defence. The revised Customs Notice provides guidance for retailers, such as pharmacies, that store medical goods but also sell goods without a public health purpose. The retailer could claim remission for medical goods imported for their own use, or prescribed to patients by health professionals, but could not claim remission for goods for general sale. Under section 2 of the Remission Order, remission is available in respect of goods imported for use in medically necessary health care services provided at hospitals, long-term care facilities, health care or dental clinics, and certain laboratories. Additionally, goods imported by or on behalf of the following entities are eligible for remission:
Commercial importers may claim remission for imported goods that are intended for immediate sale to an eligible entity described in sections 1 and 2 of the Remission Order. Under section 3 of the Remission Order, remission is available in respect of goods imported for use in manufacturing or processing of any good, or packaging of food products and beverages. According to the Customs Notice, remission is available if the importer or consignee of the goods performs the manufacturing, processing or packaging. Relief is also available for goods that are imported for immediate sale to a person who conducts these activities. The CBSA's guidelines set out in the Customs Notice do not distinguish between manufacturing and processing. Additionally, the guidelines introduce limits to eligibility for relief under the Remission Order that are not expressly referenced therein. In the Customs Notice, the CBSA explains that importers in the industries identified in the North American Industrial Classification System (NAICS) chapters 31-33 are intended to be the beneficiaries of remission based on manufacturing and processing. The Remission Order does not prescribe inclusion in the NAICS as a condition for relief.
Remission is available for manufacturing machinery and direct inputs that become an integral part of the finished product, including if the finished product is exported. With respect to packaging of food products or beverages, the Customs Notice clarifies that the Remission Order is available for goods that are used for packaging and not for the packaged goods themselves, unless the latter qualify as imports of goods used in manufacturing and processing. Remission is also not available for imports of goods that may be used for personal storage of food and beverages, such as plastic storage containers. Finally, goods that are imported for packaging food other than for human consumption (e.g., animal feed) are ineligible for remission. Finally, under section 4 of the Remission Order, relief is available in respect of goods listed in the schedule to the Remission Order. Relief is based solely on eligibility of the good itself and is not contingent on any stipulated activity associated with the importer. These goods include specialized infant formulas, medical compression garments, and sterile barrier film or pouches used in medical manufacturing. The Customs Notice emphasizes the importance of retaining documentation to support claims for remission under the Remission Order. This includes documents demonstrating that:
The Customs Notice provides special authorization codes required to obtain relief of the Surtax under the Remission Order. This information was included in the original notice. Relief for goods imported under the Courier Low Value Shipment (CLVS) program2 may be obtained using the processes described in the CBSA's Memorandums D17-4-0, Courier Low Value Shipment Program and D8-2-16, Courier Imports Remission. As noted above, the Customs Notice reflects the CBSA's interpretation of the relevant provisions of the Remission Order. Because the updated Customs Notice contains information that is not found in the Remission Order, importers should seek advice regarding the application of the Remission Order.
Document ID: 2025-1219 | ||||||||